ABBV and CNTA Related Headlines
Go Back- Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
- Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
- Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
- FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
